[go: up one dir, main page]

WO2008089003A3 - Système de stimulation optique de cellules cibles - Google Patents

Système de stimulation optique de cellules cibles Download PDF

Info

Publication number
WO2008089003A3
WO2008089003A3 PCT/US2008/050628 US2008050628W WO2008089003A3 WO 2008089003 A3 WO2008089003 A3 WO 2008089003A3 US 2008050628 W US2008050628 W US 2008050628W WO 2008089003 A3 WO2008089003 A3 WO 2008089003A3
Authority
WO
WIPO (PCT)
Prior art keywords
target cells
light
methods
vivo
stimulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/050628
Other languages
English (en)
Other versions
WO2008089003A2 (fr
Inventor
Feng Zhang
Karl Deisseroth
David J Mishelevich
M Bret Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/651,422 external-priority patent/US8926959B2/en
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Priority to US12/522,528 priority Critical patent/US10052497B2/en
Publication of WO2008089003A2 publication Critical patent/WO2008089003A2/fr
Publication of WO2008089003A3 publication Critical patent/WO2008089003A3/fr
Anticipated expiration legal-status Critical
Priority to US16/041,647 priority patent/US20180326221A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0622—Optical stimulation for exciting neural tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/065—Light sources therefor
    • A61N2005/0651—Diodes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

L'invention concerne la stimulation de cellules cibles en utilisant la lumière, par exemple, in vivo, qui est mise en œuvre en utilisant une variété de procédés et de dispositifs. Dans un exemple, les modes de réalisation impliquent des procédés de stimulation de cellules cibles en utilisant une protéine photosensible qui permet aux cellules cibles d'être stimulées en réponse à la lumière. Dans un autre exemple de mode de réalisation spécifique, les cellules cibles sont stimulées en utilisant un agencement implantable. L'agencement comprend un moyen de génération de lumière électrique pour générer de la lumière et une partie biologique. La partie biologique a un agencement biomoléculaire photosensible qui répond à la lumière générée en stimulant les cellules cibles in vivo. D'autres aspects et modes de réalisation concernent des systèmes et procédés de criblage de produits chimiques pour identifier leurs effets sur les canaux et pompes ioniques de membrane cellulaire, et des systèmes et procédés pour commander une action potentielle de neurone (par exemple, dans des environnements in vivo et in vitro).
PCT/US2008/050628 2005-07-22 2008-01-09 Système de stimulation optique de cellules cibles Ceased WO2008089003A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/522,528 US10052497B2 (en) 2005-07-22 2008-01-09 System for optical stimulation of target cells
US16/041,647 US20180326221A1 (en) 2005-07-22 2018-07-20 System for optical stimulation of target cells

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US11/651,422 2007-01-09
US11/651,422 US8926959B2 (en) 2005-07-22 2007-01-09 System for optical stimulation of target cells
US87966907P 2007-01-10 2007-01-10
US60/879,669 2007-01-10
US90430307P 2007-03-01 2007-03-01
US60/904,303 2007-03-01
US95511607P 2007-08-10 2007-08-10
US60/955,116 2007-08-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/651,422 Continuation US8926959B2 (en) 2005-07-22 2007-01-09 System for optical stimulation of target cells

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/522,528 A-371-Of-International US10052497B2 (en) 2005-07-22 2008-01-09 System for optical stimulation of target cells
US16/041,647 Continuation US20180326221A1 (en) 2005-07-22 2018-07-20 System for optical stimulation of target cells

Publications (2)

Publication Number Publication Date
WO2008089003A2 WO2008089003A2 (fr) 2008-07-24
WO2008089003A3 true WO2008089003A3 (fr) 2008-09-25

Family

ID=39636625

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/050628 Ceased WO2008089003A2 (fr) 2005-07-22 2008-01-09 Système de stimulation optique de cellules cibles

Country Status (1)

Country Link
WO (1) WO2008089003A2 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8591419B2 (en) 2008-07-14 2013-11-26 Arizona Board Of Regents For And On Behalf Of Arizona State University Methods and devices for modulating cellular activity using ultrasound
US9042201B2 (en) 2011-10-21 2015-05-26 Thync, Inc. Method and system for direct communication
US10413757B2 (en) 2012-08-29 2019-09-17 Cerevast Medical, Inc. Systems and devices for coupling ultrasound energy to a body
CN107531765B (zh) * 2015-03-19 2021-07-16 得克萨斯州大学系统董事会 阴离子通道视紫红质的组合物及其使用方法
US11771763B2 (en) 2010-04-05 2023-10-03 Eos Neuroscience, Inc. Methods and compositions for decreasing chronic pain
US12097268B2 (en) 2010-10-15 2024-09-24 Eos Neuroscience, Inc. Modulation of neural pathways

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010011404A2 (fr) 2008-05-20 2010-01-28 Eos Neuroscience, Inc. Vecteurs pour la délivrance de protéines photosensibles et procédés d’utilisation
EP2384480A2 (fr) 2008-11-26 2011-11-09 Medtronic, Inc. Collecte de données centrées sur le patient pour une vérification de compatibilité d'irm automatisée
CN101498723A (zh) * 2009-02-27 2009-08-05 深圳先进技术研究院 离子通道药物筛选装置及方法
EP2408514B1 (fr) * 2009-03-20 2017-01-25 Retina Implant AG Implant rétinien actif
DE102009061008B4 (de) * 2009-03-20 2014-09-25 Retina Implant Ag Verwendung einer Testvorrichtung und Verfahren zum Test von Zellen, Zellkulturen und/oder organotypischen Zellverbänden
US8936630B2 (en) 2009-11-25 2015-01-20 Medtronic, Inc. Optical stimulation therapy
US20120253261A1 (en) * 2011-03-29 2012-10-04 Medtronic, Inc. Systems and methods for optogenetic modulation of cells within a patient
EP2736594B1 (fr) 2011-07-25 2016-09-14 NeuroNexus Technologies, Inc. Système de transfection pour neuromodulation avec administration de fluide passive
WO2013016391A1 (fr) 2011-07-25 2013-01-31 Neuronexus Technologies, Inc. Système de transfection à neuromodulation avec amenée de fluide actif
EP2736402B1 (fr) 2011-07-25 2018-01-10 NeuroNexus Technologies, Inc. Dispositif optoélectrique et procédé de réduction d'artéfacts
US9199080B2 (en) 2011-09-12 2015-12-01 Okuvision Gmbh Method for treating an eye
WO2013056037A1 (fr) 2011-10-13 2013-04-18 The Cleveland Clinic Foundation Estimation d'une réponse neuronale à une stimulation optique
AU2019368519B2 (en) * 2018-10-26 2022-11-03 Shandong University System and method for real-time screening and measurement of cellular specific photosensitive effect
CN111690683A (zh) * 2020-05-08 2020-09-22 天津大学 一种对绿光敏感的光敏蛋白质粒的设计方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BROSENITCH ET AL.: "Physiological Patterns of Electrical Stimulation Can Induce Neuronal Gene Expressing by Activating N-Type Calcium Channels", J. OF NEUROSCIENCE, vol. 21, 2001, pages 2571 - 2579 *
SONG ET AL.: "Genes responsible for native depolarization-activated K+ currents in neurons", NEUROSCIENCE RES., vol. 42, 2002, pages 7 - 14 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8591419B2 (en) 2008-07-14 2013-11-26 Arizona Board Of Regents For And On Behalf Of Arizona State University Methods and devices for modulating cellular activity using ultrasound
US8858440B2 (en) 2008-07-14 2014-10-14 Arizona Board Of Regents For And On Behalf Of Arizona State University Methods and devices for modulating cellular activity using ultrasound
US9403038B2 (en) 2008-07-14 2016-08-02 Arizona Board Of Regents For And On Behalf Of Arizona State University Methods and devices for modulating cellular activity using ultrasound
US10556132B2 (en) 2008-07-14 2020-02-11 Arizona Board Of Regents On Behalf Of Arizona State University Methods and devices for modulating cellular activity using ultrasound
US11771763B2 (en) 2010-04-05 2023-10-03 Eos Neuroscience, Inc. Methods and compositions for decreasing chronic pain
US12097268B2 (en) 2010-10-15 2024-09-24 Eos Neuroscience, Inc. Modulation of neural pathways
US9042201B2 (en) 2011-10-21 2015-05-26 Thync, Inc. Method and system for direct communication
US9729252B2 (en) 2011-10-21 2017-08-08 Cerevast Medical, Inc. Method and system for direct communication
US10413757B2 (en) 2012-08-29 2019-09-17 Cerevast Medical, Inc. Systems and devices for coupling ultrasound energy to a body
CN107531765B (zh) * 2015-03-19 2021-07-16 得克萨斯州大学系统董事会 阴离子通道视紫红质的组合物及其使用方法

Also Published As

Publication number Publication date
WO2008089003A2 (fr) 2008-07-24

Similar Documents

Publication Publication Date Title
WO2008089003A3 (fr) Système de stimulation optique de cellules cibles
Atallah et al. Parvalbumin-expressing interneurons linearly transform cortical responses to visual stimuli
Bernstein et al. Optogenetic tools for analyzing the neural circuits of behavior
Abrahamsson et al. Thin dendrites of cerebellar interneurons confer sublinear synaptic integration and a gradient of short-term plasticity
ATE432735T1 (de) Vorrichtung zur elektrischen stimulation von biologischem material
MY169771A (en) Systems, methods and compositions for optical stimulation of target cells
WO2012101494A3 (fr) Systèmes et procédés pour détecter la stimulation nerveuse avec une prothèse implantée
EP4517318A3 (fr) Système optique pour électrophorèse capillaire
WO2007024391A3 (fr) Canaux cationiques activees par la lumiere et leurs utilisations
WO2011068696A3 (fr) Sonde neurale avec capacité de stimulation optique
AU2012209095A8 (en) Combined stimulation with controlled light distribution for electro-optical cochlear implants
DE50310674D1 (de) Verwendung von biologischen photorezeptoren als direkt lichtgesteuerte ionenkanäle
WO2005022113A3 (fr) Methodes de dosage du canal ionique
AR060954A1 (es) Sistema implantado con entradas y salidas libres de corriente continua
Song et al. Engineering of brain-like tissue constructs via 3D Cell-printing technology
Porat-Shliom et al. Mitochondrial populations exhibit differential dynamic responses to increased energy demand during exocytosis in vivo
Weiss et al. Optogenetic stimulation of the cochlea—A review of mechanisms, measurements, and first models
WO2009013219A3 (fr) Structure de bobine pour une stimulation électromagnétique d'un traitement dans un organisme vivant, dispositif utilisant une telle structure de bobine et procédé d'actionnement
Volman et al. Calcium and synaptic dynamics underlying reverberatory activity in neuronal networks
BR112021019365A2 (pt) Métodos para identificar um indivíduo que tem câncer, para selecionar uma terapia, para identificar uma interação proteína-proteína e para identificar um modulador, métodos de tratamento de um indivíduo com câncer, de identificação, de seleção de uma terapia e de identificação de um modulador, coleções de polipeptídeos, de vetores e de células e moduladores isolados
Hasenhuetl et al. A half-centre oscillator encodes sleep pressure
EP1909895A4 (fr) Systeme de stimulation cardiaque en tandem
Gu et al. Large-scale, high-density microled array-based optogenetic device for neural stimulation and recording
RU2010146628A (ru) Система и способ вызова апоптоза в клетках злокачественных опухолей с целью консервативного лечения
Binda et al. Excitation and inhibition delays within a feedforward inhibitory pathway modulate cerebellar Purkinje cell output in mice

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08727486

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08727486

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 12522528

Country of ref document: US